Insignis Therapeutics

Insignis Therapeutics is developing potentially disruptive and patient-friendly super drugs that will fundamentally transform the way we treat allergic reactions triggered by food, insect bites, and medications—reactions that can be life-threatening.Insignis Therapeutics' mission is to create an oral version of epinephrine auto-injectors like the EpiPen, empowering people with severe allergies to go wherever they want and do whatever they wish with freedom and confidence.